Skip to content
Syntara
A clinical‐stage drug development company primarily focused on blood related cancers.
Welcome
People
Board
Management
Pipeline
Cancer
Skin Scarring
Neuroinflammation
Clinical Trials
Investors
Investors home page
ASX Announcements
Quarterly Reports
Annual & Half-Yearly Reports
Investor Presentations
Videos & Podcasts
Analyst Reports
Shareholders
Shareholder Services
Corporate Governance
Contact
Welcome
People
Board
Management
Pipeline
Cancer
Skin Scarring
Neuroinflammation
Clinical Trials
Investors
Investors home page
ASX Announcements
Quarterly Reports
Annual & Half-Yearly Reports
Investor Presentations
Videos & Podcasts
Analyst Reports
Shareholders
Shareholder Services
Corporate Governance
Contact
Annual & Half-Yearly Reports
You are here:
Home
Investors
Annual & Half-Yearly Reports
Back to Investors home
ASX Announcements
Quarterly Reports
Annual & Half-Yearly Reports
Investor Presentations
Videos & Podcasts
Analyst Reports
Subscribe to email alerts
SUBSCRIBE
Go to Top
